title: The transient HIV remission in the Mississippi baby: why is this good news?
authors.affiliation: U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; jananworanich@hivresearch.org.
authors.forename: Jintanat
authors.initials: J
authors.lastname: Ananworanich
authors.affiliation: U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
authors.forename: Merlin L
authors.initials: ML
authors.lastname: Robb
mesh_terms: D000367:Age Factors; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D044966:Anti-Retroviral Agents